Neoplasia

Article	Citations
Epitranscriptomic mechanisms of androgen signalling and prostate cancer	1449
ARID1A loss sensitizes colorectal cancer cells to floxuridine	105
Single cell analysis unveils the commonality and heterogeneity between nasopharyngeal and oropharyngeal carcinoma	85
Visualizing mast cell migration to tumor sites using sodium iodide symporter of nuclear medicine reporter gene	69
Corrigendum to “Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells” [Neoplasia 17 (2014) 85]	50
Corrigendum to “Tumorigenicity of IL-1α- and IL-1β-Deficient Fibrosarcoma Cells” [Neoplasia, Volume 10, Issue 6, June 2008, Pages 549–562]	48
Sialylated IgG-activated integrin β4-Src-Erk axis stabilizes c-Myc in a p300 lysine acetyltransferase-dependent manner to promote colorectal cancer liver metastasis	46
L-methionine promotes CD8+ T cells killing hepatocellular carcinoma by inhibiting NR1I2/PCSK9 signaling	41
High metastatic tumor-derived CXCL16 mediates liver colonization metastasis by inducing Kupffer cell polarization via the PI3K/AKT/FOXO3a pathway	41
Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma	41
5-Aza-2′-deoxycytidin (Decitabine) increases cancer-testis antigen expression in head and neck squamous cell carcinoma and modifies immune checkpoint expression, especially in CD39-positive CD8 and CD	40
RUNX2 enhances bladder cancer progression by promoting glutamine metabolism	37
The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells	37
Role of heparanase 2 (Hpa2) in gastric cancer	36
Combined radio-immunotherapy: An opportunity to increase the therapeutic ratio of oligometastasis-directed radiotherapy	36
Combination of sunitinib and 177Lu-labeled antibody cG250 targeted radioimmunotherapy: A promising new therapeutic strategy for patients with advanced renal cell cancer	35
Retraction notice to “Role of Autophagy as a Survival Mechanism for Hypoxic Cells in Tumors” [Neoplasia 18 (2016) 347- 355/201]	34
Mutational signatures and their association with survival and gene expression in urological carcinomas	33
Tumor-Infiltrating Immune Cells in Colorectal Cancer	33
Time-restricted feeding affects the fecal microbiome metabolome and its diurnal oscillations in lung cancer mice	33
From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy	32
Myxoid glioneuronal tumor: Histopathologic, neuroradiologic, and molecular features in a single center series	32
Advanced progress of spatial metabolomics in head and neck cancer research	31
Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patients	30
Lactate promoted cisplatin resistance in NSCLC by modulating the m6A modification-mediated FOXO3/MAGI1-IT1/miR-664b-3p/IL-6R axis	30

The role of glycolysis in tumorigenesis: From biological aspects to therapeutic opportunities	30
Epigenetic DNA modifications and vitamin C in prostate cancer and benign prostatic hyperplasia: Exploring similarities, disparities, and pathogenic implications	30
Identification of recurrent BRAF non-V600 mutations in intraductal carcinoma of the prostate in Chinese populations	29
Innate immunity: Looking beyond T-cells in radiation and immunotherapy combinations	29
STAT3 as a mediator of oncogenic cellular metabolism: Pathogenic and therapeutic implications	28
Leptomeningeal dissemination in pediatric brain tumors	27
Incidence, mortality, and global burden of retinoblastoma in 204 countries worldwide from 1990 to 2021: Data and systematic analysis from the Global Burden of Disease Study 2021	26
Reciprocal regulation of lncRNA MEF and c-Myc drives colorectal cancer tumorigenesis	26
Aurkin-A, a TPX2-Aurora A small molecule inhibitor disrupts Alisertib-induced polyploidy in aggressive diffuse large B cell lymphoma	25
An open-label study to determine the maximum tolerated dose of oral ESK-440 administered as a single agent in patients with advanced or metastatic solid tumors	25
Ovulation sources coagulation protease cascade and hepatocyte growth factor to support physiological growth and malignant transformation	24
A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR	24
PDGF-BB overexpression in p53 null oligodendrocyte progenitors increases H3K27me3 and induces transcriptional changes which favor proliferation	24
Longitudinal genomic alternations and clonal dynamics analysis of primary malignant melanoma of the esophagus	22
Tumor-associated macrophages promote bladder cancer metastasis through the CCL20-CCR6 axis	22
Evidence based on Mendelian randomization: Causal relationship between mitochondrial biological function and lung cancer and its subtypes	22
β-Catenin mediated TAM phenotype promotes pancreatic cancer metastasis via the OSM/STAT3/LOXL2 axis	21
Molecular subtypes based on CNVs related gene signatures identify candidate prognostic biomarkers in lung adenocarcinoma	21
A systematic review of microbiome-derived biomarkers for early colorectal cancer detection	20
Inhibiting HnRNP L-mediated alternative splicing of EIF4G1 counteracts immune checkpoint blockade resistance in Castration-resistant prostate Cancer	20
Aurora kinase B is required for growth and expansion of medulloblastoma cells in the tissue context	20
Medication adjustment of afatinib and combination therapy with sitagliptin for alleviating afatinib-induced diarrhea in rats	20
Corrigendum to “SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT Pathway” [Neoplasia (2021) 23, 1037–1047]	20
SLC31A1 promotes chemoresistance through inducing CPT1A-mediated fatty acid oxidation in ER-positive breast cancer	19
Amelioration of muscle wasting by gintonin in cancer cachexia	18
Sustained experimental activation of FGF8/ERK in the developing chicken spinal cord models early events in ERK-mediated tumorigenesis	18
High dose acetaminophen re-polarizes CD11b+ cells in the tumor microenvironment towards an activated macrophage phenotype	18
Overexpression of the miR-17-92 cluster in colorectal adenoma organoids causes a carcinoma-like gene expression signature	18
Pediatric neuro-oncology: Highlights of the last quarter-century	17
Acral melanoma: new insights into the immune and genomic landscape	17
Indigenous peoples and inclusion in clinical and genomic research: Understanding the history and navigating contemporary engagement	17
Composition of gastrointestinal microbiota in association with treatment response in individuals with metastatic castrate resistant prostate cancer progressing on enzalutamide and initiating treatment	16
Circ_0089823 reinforces malignant behaviors of non-small cell lung cancer by acting as a sponge for microRNAs targeting SOX4,	16
MYH knockdown in pancreatic cancer cells creates an exploitable DNA repair vulnerability	16
MET inhibition downregulates DR4 expression in MET-amplified lung cancer cells with acquired resistance to EGFR inhibitors through suppressing AP-1-mediated transcription	16
Identification of TUBB3 as an immunotherapy target in lung cancer by genome wide in vivo CRISPR screening	16
HSP90 C-terminal domain inhibition promotes VDAC1 oligomerization via decreasing K274 mono-ubiquitination in Hepatocellular Carcinoma	16
Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1)	16
Early separation and parallel clonal selection of dedifferentiated and well-differentiated components in dedifferentiated liposarcoma	16
Whole-chromosome arm acquired uniparental disomy in cancer development is a consequence of isochromosome formation	15
Spatial profiling of METex14-altered NSCLC under tepotinib treatment: Shifting the immunosuppressive landscape	15
PAX8 modulates the tumor microenvironment of high grade serous ovarian cancer through changes in the secretome	15
Targeting glycan sulfation in a CD11c+ myeloid population inhibits early KRAS-mutant lung neoplasia	15
High-throughput sequencing and in-silico analysis confirm pathogenicity of novel MSH3 variants in African American colorectal cancer	15
Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5	14
PBI-05204, a supercritical CO2 extract of Nerium oleander, suppresses glioblastoma stem cells by inhibiting GRP78 and inducing programmed necroptotic cell death	14
Recent progress and novel approaches to treating atypical teratoid rhabdoid tumor	14
A bioluminescence reporter mouse model for visualizing and quantifying CD8+ T cells in vivo	14
Carcinogenesis induced by space radiation: A systematic review	14
Structure and function of the lysine methyltransferase SETD2 in cancer: From histones to cytoskeleton	14

miR-138-5p induces aggressive traits by targeting Trp53 expression in murine melanoma cells, and correlates with poor prognosis of melanoma patients	14
BRAF p.V600E mutation as a molecular boundary between genuine oligo-repeated and poly-metastatic disease in colorectal cancer	14
IGDQ motogenic peptide gradient induces directional cell migration through integrin (αv)β3 activation in MDA-MB-231 metastatic breast cancer cells	14
Cell competition, cooperation, and cancer	14
Corrigendum to “NFAT1 hypermethylation promotes epithelial‐mesenchymal transition and metastasis in nasopharyngeal carcinoma by activating ITGA6 transcription” [Neoplasia 21 (2019): 311–321]	13
Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma	13
Why haven't we solved intracranial pediatric ependymoma? Current questions and barriers to treatment advances.	13
Corrigendum to “Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma” [Neoplasia, Volume 21, Issue 3 (2019) 322–330]	13
Current state of pediatric neuro-oncology imaging, challenges and future directions	13
Unveiling the impact of SUMOylation at K298 site of heat shock factor 1 on glioblastoma malignant progression	13
Impact of tissue penetration and albumin binding on design of T cell targeted bispecific agents	12
Therapeutic effiacy of T cells expressing chimeric antigen receptor derived from a mesothelin-specific scFv in orthotopic human pancreatic cancer animal models	12
Combining selinexor with alisertib to target the p53 pathway in neuroblastoma	12
Corrigendum to “Tumor Therapy Mediated by Lentiviral Expression of shBcl-2 and S-TRAIL” [Neoplasia. Vol. 9, No. 5, May 2007, pp. 435–442]	12
Systemic inflammation in response to radiation drives the genesis of an immunosuppressed tumor microenvironment	12
FAPα and αSMA mark different subsets of fibroblasts in normal kidney and conventional renal cell carcinoma	12
Targeting myeloma metabolism: How abnormal metabolism contributes to multiple myeloma progression and resistance to proteasome inhibitors	12
mTORC2 regulates ribonucleotide reductase to promote DNA replication and gemcitabine resistance in non-small cell lung cancer	12
Bacterial translocation and barrier dysfunction enhance colonic tumorigenesis	12
LncRNA HOTAIRM1 promotes radioresistance in nasopharyngeal carcinoma by modulating FTO acetylation-dependent alternative splicing of CD44	12
Genomics driven precision oncology in advanced biliary tract cancer improves survival	12
Metformin use and survival in people with ovarian cancer: A population-based cohort study from British Columbia, Canada	12
Proteomic profiling of canine fibrosarcoma and adjacent peritumoral tissue	11
CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation	11
DARPP-32 and t-DARPP in the development of resistance to anti-HER2 agents. Pre-clinical evidence from the STEP study	11
Phase I clinical trial of a novel procaspase-3 activator SM-1 with temozolomide in recurrent high-grade gliomas	11
Spatial organization of heterogeneous immunotherapy target antigen expression in high-grade glioma	11
Synergizing radiotherapy and immunotherapy: Current challenges and strategies for optimization	11
Regulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cells after treatment with dutasteride and lovastatin	11
mTORC2-mediated direct phosphorylation regulates YAP activity promoting glioblastoma growth and invasive characteristics	11
Reduction in mitochondrial oxidative stress mediates hypoxia-induced resistance to cisplatin in human transitional cell carcinoma cells	11
Proprotein convertase subtilisin/kexin Type 9 is required for Ahnak-mediated metastasis of melanoma into lung epithelial cells	11
Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma	10
Hoxa11-mediated reduction of cell migration contributes to myeloid sarcoma formation induced by cooperation of MLL/AF10 with activating KRAS mutation in a mouse transplantation model	10
The renal clear cell carcinoma immune landscape	10
Resensitising proteasome inhibitor-resistant myeloma with sphingosine kinase 2 inhibition	10
Activation of the CREB Coactivator CRTC2 by Aberrant Mitogen Signaling promotes oncogenic functions in HPV16 positive head and neck cancer	10
Metformin combined with cisplatin reduces anticancer activity via ATM/CHK2-dependent upregulation of Rad51 pathway in ovarian cancer	10
Common and distinct patterns of acquired uniparental disomy and homozygous deletions between lung squamous cell carcinomas and lung adenocarcinoma	10
ΔNp63 silencing, DNA methylation shifts, and epithelial-mesenchymal transition resulted from TAp63 genome editing in squamous cell carcinoma	10
Furin, ADAM, and γ-secretase: Core regulatory targets in the Notch pathway and the therapeutic potential for breast cancer	10
Activation of PERK/eIF2α/ATF4 signaling inhibits ERα expression in breast cancer	10
AEBP1 promotes papillary thyroid cancer progression by activating BMP4 signaling	10
Maestros of malignancy: Microbes as the conductors of carcinogenesis	10
RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells	10
The kinetics of blast clearance are associated with copy number alterations in childhood B-cell acute lymphoblastic leukemia	10
Regulation of growth, invasion and metabolism of breast ductal carcinoma through CCL2/CCR2 signaling interactions with MET receptor tyrosine kinases	10
Comprehensive profiling of EGFR mutation subtypes reveals genomic-clinical associations in non-small-cell lung cancer patients on first-generation EGFR inhibitors	10
Plasma proteome alterations by MAPK inhibitors in BRAF-mutated metastatic cutaneous melanoma	9
Cardiac substructures dosimetric predicts cardiac toxicity and prognosis in esophageal squamous cell cancer treated by radiotherapy	9
RRM2 inhibition alters cell cycle through ATM/Rb/E2F1 pathway in atypical teratoid rhabdoid tumor	9
Non-melanoma skin cancers: physio-pathology and role of lipid delivery systems in new chemotherapeutic treatments	9
Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer	9
circUBR5 promotes ribosome biogenesis and induces docetaxel resistance in triple-negative breast cancer cell lines via the miR-340-5p/CMTM6/c-MYC axis	9
Copy number variation in triple negative breast cancer samples associated with lymph node metastasis	9
Histone H3 K27M-mediated regulation of cancer cell stemness and differentiation in diffuse midline glioma	9
PRMT1 methylates METTL14 to modulate its oncogenic function	9
The antitumor activity of osimertinib plus palbociclib in non-small cell lung cancer patient-derived xenograft (PDX)/2D/3D culture models harboring EGFR amplification and CDKN2A/2B homozygous deletion	9
Decoding androgen receptor signalling: Genomic vs. non-genomic roles in prostate cancer	9
Targeting interleukin 4 receptor alpha on tumor-associated macrophages reduces the pro-tumor macrophage phenotype	9
Clinical and genetic drivers of oligo-metastatic disease in colon cancer	9
Cholesterol and saturated fatty acids synergistically promote the malignant progression of prostate cancer	9
Myelodysplastic syndromes: Biological and therapeutic consequences of the evolving molecular aberrations landscape	8
Tackling ALT-positive neuroblastoma: is it time to redefine risk classification systems? A systematic review with IPD meta-analysis	8
Hedgehog/GLI1 Transcriptionally Regulates FANCD2 in Ovarian Tumor Cells: Its Inhibition Induces HR-Deficiency and Synergistic Lethality with PARP Inhibition.	8
Post-irradiation intratumoral heterogeneity modulates response to immune checkpoint inhibition therapy in a murine melanoma model	8
Non-canonical olfactory pathway activation induces cell fusion of cervical cancer cells	8
Modulation of mitochondrial function by extracellular acidosis in tumor cells and normal fibroblasts: Role of signaling pathways	8
IL-6 facilitates cross-talk between epithelial cells and tumor- associated macrophages in Helicobacter pylori-linked gastric carcinogenesis	8
p85β alters response to EGFR inhibitor in ovarian cancer through p38 MAPK-mediated regulation of DNA repair	8
RETRACTED: Inhibition of HDACs reduces Ewing sarcoma tumor growth through EWS-FLI1 protein destabilization	8
Genomic landscape and evolution of arm aneuploidy in lung adenocarcinoma	8
Mitochondrial adaptation decreases drug sensitivity of persistent triple negative breast cancer cells surviving combinatory and sequential chemotherapy	8
Tumor-associated tissue eosinophilia promotes angiogenesis and metastasis in head and neck squamous cell carcinoma	8
Machine Learning-assisted immunophenotyping of peripheral blood identifies innate immune cells as best predictor of response to induction chemo-immunotherapy in head and neck squamous cell carcinoma –	8
The promise of metabolic imaging in diffuse midline glioma	8
Galectin-3 secreted by triple-negative breast cancer cells regulates T cell function	8
Selective BH3 mimetics synergize with BET inhibition to induce mitochondrial apoptosis in rhabdomyosarcoma cells	8
LGR6-dependent conditional inactivation of E-cadherin and p53 leads to invasive skin and mammary carcinomas in mice	7
Prenatal p25-activated Cdk5 induces pituitary tumorigenesis through MCM2 phosphorylation-mediated cell proliferation	7

Past, present and future of Focused Ultrasound as an adjunct or complement to DIPG/DMG therapy: A consensus of the 2021 FUSF DIPG meeting	7
Molecular heterogeneity in histomorphologic subtypes of lung adeno carcinoma represents a challenge for treatment decision	7
Diet-microbiome interactions in cancer treatment: Opportunities and challenges for precision nutrition in cancer	7
Microbial molecules, metabolites, and malignancy	7
In vivo two-photon characterization of tumor-associated macrophages and microglia (TAM/M) and CX3CR1 during different steps of brain metastasis formation from lung cancer	7
Therapeutic avenues for targeting treatment challenges of diffuse midline gliomas	7
Hepatocellular loss of mTOR aggravates tumor burden in nonalcoholic steatohepatitis-related HCC	7
The pan-cancer landscape of abnormal DNA methylation and intratumor microorganisms	7
The breast tissue microbiome, stroma, immune cells and breast cancer	7
The chemokine CX3CL1 promotes intraperitoneal tumour growth despite enhanced T-cell recruitment in ovarian cancer	7
Overcoming ABCB1-mediated multidrug resistance by transcription factor BHLHE40	6
S-adenosylmethionine blocks tumorigenesis and with immune checkpoint inhibitor enhances anti-cancer efficacy against BRAF mutant and wildtype melanomas	6
Depletion of β1,6-N-acetylglucosaminyltransferase reduces E-selectin binding capacity and migratory potential of human gastrointestinal adenocarcinoma cells	6
Sequential treatment of anti-PD-L1 therapy prior to anti-VEGFR2 therapy contributes to more significant clinical benefits in non-small cell lung cancer	6
Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic cancer models for therapeutic testing	6
Extracellular signals induce dynamic ER remodeling through αTAT1-dependent microtubule acetylation	6
Panobinostat enhances olaparib efficacy by modifying expression of homologous recombination repair and immune transcripts in ovarian cancer	6
A mutual information-based in vivo monitoring of adaptive response to targeted therapies in melanoma	6
Granulocyte-macrophage colony-stimulating factor for newly diagnosed glioblastoma	6
Mathematical modeling of radiotherapy and its impact on tumor interactions with the immune system	6
Comparison of adjuvant gemcitabine plus S-1 with S-1 monotherapy for pancreatic ductal adenocarcinoma: Retrospective real-world data	6
Kv11.1-dependent senescence activates a lethal immune response via tumor necrosis factor alpha	6
An antibody targeting an immune checkpoint molecule BTN2A2 enhances anti-tumor immunity	6
Engineering and characterization of Hu3A4: A novel humanized antibody with potential as a therapeutic agent against myeloid lineage leukemias	6
Suppression of ER-stress induction of GRP78 as an anti-neoplastic mechanism of the cardiac glycoside Lanatoside C in pancreatic cancer	6
MLH1 mediates cytoprotective nucleophagy to resist 5-Fluorouracil-induced cell death in colorectal carcinoma	5
SOMCL-19-133, a novel, selective, and orally available inhibitor of NEDD8-activating enzyme (NAE) for cancer therapy	5
PI3K-CCL2-CCR2-MDSCs axis: A potential pathway for tumor Clostridia-promoted CD 8+ T lymphocyte infiltration in bile tract cancers	5
STAT3 contributes to cisplatin resistance, modulating EMT markers, and the mTOR signaling in lung adenocarcinoma	5
Corrigendum to “Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E” [Neoplasia, volume 12,	5
Exosomes in review: A new frontier in CAR-T cell therapies	5
A synergistic approach for modulating the tumor microenvironment to enhance nano-immunotherapy in sarcomas	5
Cell communication pathway prognostic model identified detrimental neurodevelopmental pathways in neuroblastoma	5
Comparison of differences in transcriptional and genetic profiles between intra-central nervous system and extra-central nervous system large B-cell lymphoma	5
YPEL2 regulates the efficacy of BRD4-EZH2 dual targeting in EZH2Y641mut germinal center-derived lymphoma	5
Insights into the metastatic bone marrow niche gained from fibronectin and β1 integrin transgenic mice	5
Comprehensive genomic profiling of Finnish lung adenocarcinoma cohort reveals high clinical actionability and SMARCA4 altered tumors with variable histology and poor prognosis	5
Corrigendum to Hypoxia induces docetaxel resistance in triple-negative breast cancer via the HIF-1 α/miR-494/Survivin signaling pathway [Volume 32 Number xxx Month 2022 pp. 100821]	5
Global molecular alterations involving recurrence or progression of pediatric brain tumors	5
DCZ0014, a novel compound in the therapy of diffuse large B-cell lymphoma via the B cell receptor signaling pathway	5
Retraction notice to Corrigendum to “Inhibition of HDACs reduces Ewing sarcoma tumor growth through EWS-FLI1 protein destabilization” [Neoplasia 31 (2022) 100805]	4
Pharmacological inhibition of the SKP2/p300 signaling axis restricts castration-resistant prostate cancer	4
Efficacy and safety of pyrotinib-based regimens in HER2 positive metastatic breast cancer: A retrospective real-world data study	4
True cancer stem cells exhibit relative degrees of dormancy and genomic stability	4
A trio of tumor suppressor miRNA downregulates CREB5 dependent transcription to modulate neoadjuvant hormonal therapy sensitivity	4
Characterization and integrated analysis of extrachromosomal DNA amplification in hematological malignancies	4
Retraction notice to “Inhibition of HDACs reduces Ewing sarcoma tumor growth through EWS-FLI1 protein destabilization” [Neoplasia 27 (2022) 100784]	4
Copy number alteration of the interferon gene cluster in cancer: Individual patient data meta-analysis prospects to personalized immunotherapy	4
Corrigendum to “Hedgehog/GLI1 Transcriptionally Regulates FANCD2 in Ovarian Tumor Cells: Its Inhibition Induces HR-Deficiency and Synergistic Lethality with PARP Inhibition.” [Neoplasia Volume 23, Iss	4
Who benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-dimensional model for candidate selection	4
GRP78 inhibitor YUM70 upregulates 4E-BP1 and suppresses c-MYC expression and viability of oncogenic c-MYC tumors	4
Effect of MisMatch repair deficiency on metastasis occurrence in a syngeneic mouse model	4
FABP4 facilitates epithelial-mesenchymal transition via elevating CD36 expression in glioma cells	4
Influence of alectinib and crizotinib on ionizing radiation - in vitro analysis of ALK/ROS1-wildtype lung tissue cells	4
Clinical utility and predictive value of cerebrospinal fluid cell-free DNA profiling in non-small cell lung cancer patients with leptomeningeal metastasis	4
Towards a molecular understanding of the overlapping and distinct roles of UBQLN1 and UBQLN2 in lung cancer progression and metastasis	4
Specifying the choice of EGFR-TKI based on brain metastatic status for advanced NSCLC with EGFR p.L861Q mutation	4
Establishing a comprehensive panel of patient-derived xenograft models for high-grade endometrial carcinoma: molecular subtypes, genetic alterations, and therapeutic target profiling	4
Radiotherapy combined with docetaxel alters the immune phenotype of HNSCC cells and results in increased surface expression of CD137 and release of HMGB1 of specifically HPV-positive tumor cells	4
Proteome biology of primary colorectal carcinoma and corresponding liver metastases	4
Disruption of redox balance in glutaminolytic triple negative breast cancer by inhibition of glutaminase and glutamate export	4
Mcl-1 levels critically impact the sensitivities of human colorectal cancer cells to APG-1252-M1, a novel Bcl-2/Bcl-XL dual inhibitor that induces Bax-dependent apoptosis	3
Construction of self-driving anti-αFR CAR-engineered NK cells based on IFN-γ and TNF-α synergistically induced high expression of CXCL10	3
Patient recruitment into clinical studies of solid malignancies during the COVID-19 pandemic in a tertiary cancer center	3
Antibiotic treatment targeting gram negative bacteria prevents neratinib-induced diarrhea in rats	3
O-GlcNAc-modified HOXA9 suppresses ferroptosis via promoting UBR5-mediated SIRT6 degradation in nasopharyngeal carcinoma	3
Druggable gene alterations in Japanese patients with rare malignancy	3
Characterization of circulating tumor cells in patients with metastatic bladder cancer utilizing functionalized microfluidics	3
RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer	3
Lipolysis-stimulated lipoprotein receptor-targeted antibody-drug conjugate demonstrates potent antitumor activity against epithelial ovarian cancer	3
Dihydroartemisinin, a potential PTGS1 inhibitor, potentiated cisplatin-induced cell death in non-small cell lung cancer through activating ROS-mediated multiple signaling pathways	3
Transcriptomic and proteomic profiling identifies feline fibrosarcoma as clinically amenable model for aggressive sarcoma subtypes	3
Metabolic reprogramming by adenosine antagonism and implications in non-small cell lung cancer therapy	3
Secondary basophilic leukemia in Ph-negative myeloid neoplasms: A distinct subset with poor prognosis	3
Interdisciplinary care of children with diffuse midline glioma	3
A new, simplified endoscopic scoring system for predicting clinical outcome in gastric low-grade intraepithelial neoplasia: the “e-cout system”	3
Genomic landscape of metastatic lung adenocarcinomas from large-scale clinical sequencing	3
Oncogene-independent resistance in Philadelphia chromosome - positive (Ph+) acute lymphoblastic leukemia (ALL) is mediated by activation of AKT/mTOR pathway	3
Targeting IL-23 for the interception of obesity-associated colorectal cancer	3
Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology	3
Pediatric low-grade glioma: Targeted therapeutics and clinical trials in the molecular era	3
Non-redundant roles of the CCR1 and CCR2 chemokine axes in monocyte recruitment during lung metastasis	3
PIK3R1 fusion drives chemoresistance in ovarian cancer by activating ERK1/2 and inducing rod and ring-like structures	3
Effects of PYCR1 on prognosis and immunotherapy plus tyrosine kinase inhibition responsiveness in metastatic renal cell carcinoma patients	3
Enhanced Apc adenoma formation after epithelial CUL4B deletion by recruitment of myeloid-derived suppressor cells	3
Identification of 68 HLA-A24 and -A2-restricted cytotoxic T lymphocyte-inducing peptides derived from 10 common cancer-specific antigens frequently expressed in various solid cancers	3
Altered endosomal-lysosomal biogenesis in melanoma	3
Ovulation sources ROS to confer mutagenic activities on the TP53 gene in the fallopian tube epithelium	3
Subclonal evolution and expansion of spatially distinct THY1-positive cells is associated with recurrence in glioblastoma	3
Identification and characterization of circular RNAs as novel putative biomarkers to predict anti-PD-1 monotherapy response in metastatic melanoma patients – Knowledge from two independent internation	3
Corrigendum to “NF-κB p65 Overexpression Promotes Bladder Cancer Cell Migration via FBW7-Mediated Degradation of RhoGDIα Protein” [Neoplasia 19 (2017) 672–683]	3
Emerging role of necroptosis, pyroptosis, and ferroptosis in breast cancer: New dawn for overcoming therapy resistance	3